Skip to main content
. 2008 Apr;10(2):162–170. doi: 10.1215/15228517-2007-062

Fig. 1.

Fig. 1

Survival from 6 months after study registration for patients with grade III gliomas who were alive at that time, comparing survival for patients who had disease progression (solid line) with survival for those who did not have progression (dashed line) by 6 months.